-
11دورية أكاديمية
المؤلفون: Georgiou, L, Wilson, DJ, Sharma, N, Perren, TJ, Buckley, DL
وصف الملف: text
العلاقة: https://eprints.whiterose.ac.uk/136005/1/Final%20accepted%20manuscript.pdfTest; Georgiou, L, Wilson, DJ, Sharma, N et al. (2 more authors) (2019) A functional form for a representative individual arterial input function measured from a population using high temporal resolution DCE MRI. Magnetic Resonance in Medicine, 81 (3). pp. 1955-1963. ISSN 0740-3194
-
12دورية أكاديمية
المؤلفون: Hall, M, Bertelli, G, Li, L, Green, C, Chan, S, Yeoh, CC, Hasan, Jurjees, Jones, R, Ograbek, A, Perren, TJ
المساهمون: Mount Vernon Cancer Centre, Northwood, UK
العلاقة: https://dx.doi.org/10.1136/ijgc-2019-000512Test; Hall M, Bertelli G, Li L, Green C, Chan S, Yeoh CC, et al. Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study. Int J Gynecol Cancer. 2019.; http://hdl.handle.net/10541/622643Test; International journal of gynecological cancer
-
13
المؤلفون: González Martín A, Oza AM, Embleton AC, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Bertrand MA, Beale P, Cervantes A, Kent E, Kaplan RS, Parmar MKB, Scotto N, Perren TJ, ICON7 investigators
المصدر: GYNECOLOGIC ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instnameالوصول الحر: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::614e9481d185aa20c051dc19e11b3fa5Test
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2429Test -
14دورية أكاديمية
المؤلفون: Adams, M, Calvert, AH, Carmichael, J, Clark, PI, Coleman, RE, Earl, HM, Gallagher, CJ, Ganesan, TS, Gore, ME, Graham, JD, Harper, PG, Jayson, GC, Kaye, SB, Ledermann, JA, Osborne, RJ, Perren, TJ, Poole, CJ, Radford, JA, Rustin, GJS, Slevin, ML, Smyth, JF, Thomas, H, Wilkinson, PM
المصدر: British Journal of Cancer ; volume 78, issue 11, page 1404-1406 ; ISSN 0007-0920 1532-1827
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1038/bjc.1998.699Test
https://www.nature.com/articles/bjc1998699.pdfTest
https://www.nature.com/articles/bjc1998699Test -
15دورية أكاديمية
المؤلفون: Perren, TJ
المصدر: British Journal of Cancer ; volume 71, issue 6, page 1142-1144 ; ISSN 0007-0920 1532-1827
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1038/bjc.1995.223Test
https://www.nature.com/articles/bjc1995223.pdfTest
https://www.nature.com/articles/bjc1995223Test -
16دورية أكاديمية
المؤلفون: Perren, TJ, Wiltshaw, E, Harper, P, Slevin, M, Stein, R, Tan, S, Gore, M, Fryatt, IJ, Blake, PR
المصدر: British Journal of Cancer ; volume 68, issue 6, page 1190-1194 ; ISSN 0007-0920 1532-1827
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1038/bjc.1993.502Test
http://www.nature.com/articles/bjc1993502.pdfTest
http://www.nature.com/articles/bjc1993502Test -
17دورية أكاديمية
المؤلفون: Perren, TJ
المصدر: British Journal of Cancer ; volume 63, issue 3, page 328-332 ; ISSN 0007-0920 1532-1827
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1038/bjc.1991.78Test
https://www.nature.com/articles/bjc199178.pdfTest
https://www.nature.com/articles/bjc199178Test -
18دورية أكاديمية
المؤلفون: Lakhani, S, Selby, P, Bliss, JM, Perren, TJ, Gore, ME, McElwain, TJ
المصدر: British Journal of Cancer ; volume 61, issue 2, page 330-334 ; ISSN 0007-0920 1532-1827
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1038/bjc.1990.65Test
http://www.nature.com/articles/bjc199065.pdfTest
http://www.nature.com/articles/bjc199065Test -
19دورية أكاديمية
المؤلفون: Ledermann, JA, Embleton, AC, Raja, F, Perren, TJ, Jayson, GC, Rustin, GJS, Kaye, SB, Hirte, H, Eisenhauer, E, Vaughan, M, Friedlander, M, Gonzalez-Martin, A, Stark, D, Clark, E, Farrelly, L, Swart, AM, Cook, A, Kaplan, RS, Parmar, MKB
العلاقة: Ledermann, JA, Embleton, AC, Raja, F et al. (16 more authors) (2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 387 (10023). pp. 1066-1074. ISSN 0140-6736
-
20
المؤلفون: Oza, AM, Cook, AD, Pfisterer, J, Embleton, A, Ledermann, JA, Pujade-Lauraine, E, Kristensen, G, Carey, MS, Beale, P, Cervantes, A, Park-Simon, T-W, Rustin, G, Joly, F, Mirza, MR, Plante, M, Quinn, M, Poveda, A, Jayson, GC, Stark, D, Swart, AM, Farrelly, L, Kaplan, R, Parmar, MKB, Perren, TJ
المصدر: Oza, A M, Cook, A D, Pfisterer, J, Embleton, A, Ledermann, J A, Pujade-Lauraine, E, Kristensen, G, Carey, M S, Beale, P, Cervantes, A, Park-Simon, T-W, Rustin, G, Joly, F, Mirza, M R, Plante, M, Quinn, M S, Poveda, A, Jayson, G C, Stark, D, Swart, A M, Farrelly, L, Kaplan, R, Parmar, M K B, Perren, T J & ICON7 trial investigators 2015, ' Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7) : overall survival results of a phase 3 randomised trial ', Lancet Oncology, vol. 16, no. 8, pp. 928-936 . https://doi.org/10.1016/S1470-2045Test(15)00086-8
مصطلحات موضوعية: Canada, Time Factors, Paclitaxel, Clinical Trial, Phase III, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Drug Administration Schedule, Carboplatin, Antineoplastic Combined Chemotherapy Protocols, Journal Article, Humans, Infusions, Intravenous, Neoplasm Staging, Ovarian Neoplasms, Research Support, Non-U.S. Gov't, Australia, Survival Analysis, Intention to Treat Analysis, Bevacizumab, Europe, Multicenter Study, Treatment Outcome, Oncology, Randomized Controlled Trial, Disease Progression, Female, Neoplasm Grading, New Zealand
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8dee481155bef518cb7d7907f28f5f8fTest
https://vbn.aau.dk/da/publications/eb7eb733-cabd-47b8-b97c-4c9966777fa3Test
